Skip to content
healthcare.dev

bosentan

NDC 70710-1508, bosentan, tablet, for suspension, from Zydus Pharmaceuticals USA Inc..

Product NDC
70710-1508
Status
Listed
Labeler
Zydus Pharmaceuticals USA Inc.
Dosage form
TABLET, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213981
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1508 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BOSENTAN32 mg/1

Pharmacologic classes

Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A Inducers [MoA]; Endothelin Receptor Antagonist [EPC]; Endothelin Receptor Antagonists [MoA]

Package NDCNDC-11Package
70710-1508-8707101508084 BLISTER PACK in 1 CARTON (70710-1508-8) / 14 TABLET, FOR SUSPENSION in 1 BLISTER PACK (70710-1508-7)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c1e75179-cbea-4535-8709-f6d79c1d4004

Use it

Look up 70710-1508 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1508 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70710-1508. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.